The Japanese experience and pharmacokinetics of antenatal maternal high-dose immunoglobulin treatment as a prophylaxis for neonatal hemochromatosis in siblings

Autor:	Hirokazu Tanaka, Chiaki Tenkumo, Yuka Wada, Jumpei Saito, Noriki Okada, Hidefumi Nakamura, Koshi Yamaguchi, Akihiro Yachie, Mayumi Sako, Yusuke Mitani, Junko Nagasawa, Hironori Takahashi, Aiko Sasaki, Toshiyuki Hata, Koichi Mizuta, Kenji Matsumoto, Kenichiro Motomura, Haruhiko Sago, Shigeki Matsubara
Rok vydání:	2018
Předmět:	Adult Pediatrics medicine.medical_specialty Disease Chemoprevention 03 medical and health sciences 0302 clinical medicine Fulminant hepatic failure Japan Pharmacokinetics Pregnancy Recurrence Secondary Prevention Neonatal hemochromatosis Humans Medicine Infusions Intravenous Reproductive History Retrospective Studies 030219 obstetrics & reproductive medicine Dose-Response Relationship Drug biology business.industry Siblings Infant Newborn Pregnancy Outcome Immunoglobulins Intravenous Obstetrics and Gynecology Prenatal Care medicine.disease Treatment Outcome Pediatrics Perinatology and Child Health biology.protein Female 030211 gastroenterology & hepatology Hemochromatosis Antibody business
Zdroj:	The Journal of Maternal-Fetal & Neonatal Medicine. 33:142-148
ISSN:	1476-4954 1476-7058
DOI:	10.1080/14767058.2018.1487940
Popis:	Background: Neonatal hemochromatosis (NH) is a rare but serious disease causing fulminant hepatic failure. The recurrence rate of NH in a subsequent infant of a mother with an affected infant is 70...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c87614f7b24265204c69a1accd26adb https://doi.org/10.1080/14767058.2018.1487940 Zobrazit plný text záznamu